2024-03-15 |
2024-03-15 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
329
-0.0%
41.23
13,565
USD
|
329
-0.0%
|
41.23
|
13,565
USD
|
|
2024-03-15 |
2024-03-15 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
10,411
-1.3%
40.62
422,895
USD
|
10,411
-1.3%
|
40.62
|
422,895
USD
|
|
2024-03-15 |
2024-03-15 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
1,714
-0.2%
39.31
67,377
USD
|
1,714
-0.2%
|
39.31
|
67,377
USD
|
|
2024-03-15 |
2024-03-15 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
1,593
-0.0%
41.23
65,679
USD
|
1,593
-0.0%
|
41.23
|
65,679
USD
|
|
2024-03-15 |
2024-03-15 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
49,591
-1.1%
40.62
2,014,386
USD
|
49,591
-1.1%
|
40.62
|
2,014,386
USD
|
|
2024-03-15 |
2024-03-15 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
8,126
-0.2%
39.31
319,433
USD
|
8,126
-0.2%
|
39.31
|
319,433
USD
|
|
2024-03-15 |
2024-03-14 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
154
-0.0%
41.51
6,393
USD
|
154
-0.0%
|
41.51
|
6,393
USD
|
|
2024-03-15 |
2024-03-14 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
2,233
-0.3%
40.66
90,794
USD
|
2,233
-0.3%
|
40.66
|
90,794
USD
|
|
2024-03-15 |
2024-03-14 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
7,292
-0.9%
39.73
289,711
USD
|
7,292
-0.9%
|
39.73
|
289,711
USD
|
|
2024-03-15 |
2024-03-14 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
781
-0.0%
41.51
32,419
USD
|
781
-0.0%
|
41.51
|
32,419
USD
|
|
2024-03-15 |
2024-03-14 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
10,846
-0.2%
40.66
440,998
USD
|
10,846
-0.2%
|
40.66
|
440,998
USD
|
|
2024-03-15 |
2024-03-14 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
34,473
-0.7%
39.73
1,369,612
USD
|
34,473
-0.7%
|
39.73
|
1,369,612
USD
|
|
2024-03-13 |
2024-03-13 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
1,386
-0.2%
42.84
59,376
USD
|
1,386
-0.2%
|
42.84
|
59,376
USD
|
|
2024-03-13 |
2024-03-13 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
22,779
-2.7%
42.19
961,046
USD
|
22,779
-2.7%
|
42.19
|
961,046
USD
|
|
2024-03-13 |
2024-03-13 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
6,686
-0.1%
42.84
286,428
USD
|
6,686
-0.1%
|
42.84
|
286,428
USD
|
|
2024-03-13 |
2024-03-13 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
108,404
-2.3%
42.19
4,573,565
USD
|
108,404
-2.3%
|
42.19
|
4,573,565
USD
|
|
2024-03-13 |
2024-03-13 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
1,386
-0.2%
42.84
59,376
USD
|
1,386
-0.2%
|
42.84
|
59,376
USD
|
|
2024-03-13 |
2024-03-13 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
22,779
-2.7%
42.19
961,046
USD
|
22,779
-2.7%
|
42.19
|
961,046
USD
|
|
2024-03-13 |
2024-03-13 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
6,686
-0.1%
42.84
286,428
USD
|
6,686
-0.1%
|
42.84
|
286,428
USD
|
|
2024-03-13 |
2024-03-13 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
108,404
-2.3%
42.19
4,573,565
USD
|
108,404
-2.3%
|
42.19
|
4,573,565
USD
|
|
2024-03-13 |
2024-03-12 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
1,819
-0.2%
42.52
77,344
USD
|
1,819
-0.2%
|
42.52
|
77,344
USD
|
|
2024-03-13 |
2024-03-12 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
26,452
-3.0%
41.94
1,109,397
USD
|
26,452
-3.0%
|
41.94
|
1,109,397
USD
|
|
2024-03-13 |
2024-03-12 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
8,581
-0.2%
42.52
364,864
USD
|
8,581
-0.2%
|
42.52
|
364,864
USD
|
|
2024-03-13 |
2024-03-12 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
126,066
-2.6%
41.94
5,287,208
USD
|
126,066
-2.6%
|
41.94
|
5,287,208
USD
|
|
2024-03-13 |
2024-03-12 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
1,819
-0.2%
42.52
77,344
USD
|
1,819
-0.2%
|
42.52
|
77,344
USD
|
|
2024-03-13 |
2024-03-12 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
26,452
-3.0%
41.94
1,109,397
USD
|
26,452
-3.0%
|
41.94
|
1,109,397
USD
|
|
2024-03-13 |
2024-03-12 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
8,581
-0.2%
42.52
364,864
USD
|
8,581
-0.2%
|
42.52
|
364,864
USD
|
|
2024-03-13 |
2024-03-12 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
126,066
-2.6%
41.94
5,287,208
USD
|
126,066
-2.6%
|
41.94
|
5,287,208
USD
|
|
2024-03-13 |
2024-03-11 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
1,045
-0.1%
43.42
45,374
USD
|
1,045
-0.1%
|
43.42
|
45,374
USD
|
|
2024-03-13 |
2024-03-11 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
7,837
-0.9%
42.77
335,188
USD
|
7,837
-0.9%
|
42.77
|
335,188
USD
|
|
2024-03-13 |
2024-03-11 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
5,122
-0.1%
43.42
222,397
USD
|
5,122
-0.1%
|
43.42
|
222,397
USD
|
|
2024-03-13 |
2024-03-11 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
37,180
-0.7%
42.77
1,590,189
USD
|
37,180
-0.7%
|
42.77
|
1,590,189
USD
|
|
2024-03-13 |
2024-03-11 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
1,045
-0.1%
43.42
45,374
USD
|
1,045
-0.1%
|
43.42
|
45,374
USD
|
|
2024-03-13 |
2024-03-11 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
7,837
-0.9%
42.77
335,188
USD
|
7,837
-0.9%
|
42.77
|
335,188
USD
|
|
2024-03-13 |
2024-03-11 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
5,122
-0.1%
43.42
222,397
USD
|
5,122
-0.1%
|
43.42
|
222,397
USD
|
|
2024-03-13 |
2024-03-11 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
37,180
-0.7%
42.77
1,590,189
USD
|
37,180
-0.7%
|
42.77
|
1,590,189
USD
|
|
2024-03-04 |
2024-03-04 |
S
Sale
|
Gollob Jared
Chief Medical Officer
Officer
|
216
-0.2%
43.26
9,343
USD
|
216
-0.2%
|
43.26
|
9,343
USD
|
|
2024-03-04 |
2024-03-04 |
S
Sale
|
Gollob Jared
Chief Medical Officer
Officer
|
1,106
-1.1%
42.39
46,886
USD
|
1,106
-1.1%
|
42.39
|
46,886
USD
|
|
2024-03-04 |
2024-03-04 |
S
Sale
|
Gollob Jared
Chief Medical Officer
Officer
|
2,022
-2.0%
41.41
83,738
USD
|
2,022
-2.0%
|
41.41
|
83,738
USD
|
|
2024-03-04 |
2024-03-04 |
S
Sale
|
Jacobs Bruce N.
Chief Financial Officer
Officer
|
255
-0.2%
43.26
11,030
USD
|
255
-0.2%
|
43.26
|
11,030
USD
|
|
2024-03-04 |
2024-03-04 |
S
Sale
|
Jacobs Bruce N.
Chief Financial Officer
Officer
|
1,301
-0.9%
42.39
55,153
USD
|
1,301
-0.9%
|
42.39
|
55,153
USD
|
|
2024-03-04 |
2024-03-04 |
S
Sale
|
Jacobs Bruce N.
Chief Financial Officer
Officer
|
2,378
-1.6%
41.41
98,481
USD
|
2,378
-1.6%
|
41.41
|
98,481
USD
|
|
2024-02-29 |
2024-02-27 |
PS
Planned sale
|
Gollob Jared
Chief Medical Officer
Officer
|
400
-0.5%
45.00
18,000
USD
|
400
-0.5%
|
45.00
|
18,000
USD
|
|
2024-02-21 |
2024-02-21 |
PS
Planned sale
|
Albers Jeffrey W.
Non-Executive Director
|
4,385
-100.0%
39.05
171,227
USD
|
4,385
-100.0%
|
39.05
|
171,227
USD
|
|
2024-02-21 |
2024-02-20 |
PS
Planned sale
|
Albers Jeffrey W.
Non-Executive Director
|
615
-100.0%
39.07
24,031
USD
|
615
-100.0%
|
39.07
|
24,031
USD
|
|
2024-02-09 |
2024-02-09 |
PS
Planned sale
|
Gollob Jared
Chief Medical Officer
Officer
|
7,398
-9.0%
36.09
267,013
USD
|
7,398
-9.0%
|
36.09
|
267,013
USD
|
|
2024-02-09 |
2024-02-09 |
PS
Planned sale
|
Gollob Jared
Chief Medical Officer
Officer
|
38,739
-32.1%
35.39
1,371,058
USD
|
38,739
-32.1%
|
35.39
|
1,371,058
USD
|
|
2024-01-23 |
2024-01-23 |
PS
Planned sale
|
Albers Jeffrey W.
Non-Executive Director
|
10,000
-100.0%
30.05
300,470
USD
|
10,000
-100.0%
|
30.05
|
300,470
USD
|
|
2024-01-05 |
2024-01-04 |
S
Sale
|
Chiniara Ellen
Chief Legal Officer
Officer
|
3,295
-8.8%
22.58
74,416
USD
|
3,295
-8.8%
|
22.58
|
74,416
USD
|
|
2023-11-06 |
2023-11-03 |
B
Purchase
|
BVF PARTNERS L P/IL
Non-Executive Director
|
10,106
+3.6%
14.07
142,180
USD
|
10,106
+3.6%
|
14.07
|
142,180
USD
|
|
2023-11-06 |
2023-11-03 |
B
Purchase
|
BVF PARTNERS L P/IL
Non-Executive Director
|
83,708
+4.1%
14.07
1,177,679
USD
|
83,708
+4.1%
|
14.07
|
1,177,679
USD
|
|
2023-11-06 |
2023-11-03 |
B
Purchase
|
BVF PARTNERS L P/IL
Non-Executive Director
|
103,885
+4.1%
14.07
1,461,548
USD
|
103,885
+4.1%
|
14.07
|
1,461,548
USD
|
|
2023-11-06 |
2023-11-02 |
B
Purchase
|
BVF PARTNERS L P/IL
Non-Executive Director
|
26,772
+10.4%
11.64
311,744
USD
|
26,772
+10.4%
|
11.64
|
311,744
USD
|
|
2023-11-06 |
2023-11-02 |
B
Purchase
|
BVF PARTNERS L P/IL
Non-Executive Director
|
132,016
+7.0%
11.64
1,537,247
USD
|
132,016
+7.0%
|
11.64
|
1,537,247
USD
|
|
2023-11-06 |
2023-11-02 |
B
Purchase
|
BVF PARTNERS L P/IL
Non-Executive Director
|
57,618
+2.3%
11.64
670,927
USD
|
57,618
+2.3%
|
11.64
|
670,927
USD
|
|
2023-03-03 |
2023-03-02 |
PS
Planned sale
|
Gollob Jared
Chief Medical Officer
Officer
|
297
-0.4%
31.40
9,325
USD
|
297
-0.4%
|
31.40
|
9,325
USD
|
|
2023-03-03 |
2023-03-02 |
PS
Planned sale
|
Gollob Jared
Chief Medical Officer
Officer
|
1,001
-1.3%
30.88
30,908
USD
|
1,001
-1.3%
|
30.88
|
30,908
USD
|
|
2023-03-03 |
2023-03-02 |
PS
Planned sale
|
Jacobs Bruce N.
Chief Financial Officer
Officer
|
314
-0.3%
31.40
9,859
USD
|
314
-0.3%
|
31.40
|
9,859
USD
|
|
2023-03-03 |
2023-03-02 |
PS
Planned sale
|
Jacobs Bruce N.
Chief Financial Officer
Officer
|
1,056
-1.0%
30.88
32,607
USD
|
1,056
-1.0%
|
30.88
|
32,607
USD
|
|
2023-03-03 |
2023-03-02 |
PS
Planned sale
|
Caughey Elaine
Chief Business Officer
Officer
|
164
-0.9%
31.40
5,149
USD
|
164
-0.9%
|
31.40
|
5,149
USD
|
|
2023-03-03 |
2023-03-02 |
PS
Planned sale
|
Caughey Elaine
Chief Business Officer
Officer
|
550
-2.8%
30.88
16,983
USD
|
550
-2.8%
|
30.88
|
16,983
USD
|
|
2023-01-13 |
2023-01-12 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
21,592
-2.4%
30.29
654,022
USD
|
21,592
-2.4%
|
30.29
|
654,022
USD
|
|
2023-01-13 |
2023-01-12 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
77,128
-1.5%
30.29
2,336,207
USD
|
77,128
-1.5%
|
30.29
|
2,336,207
USD
|
|
2023-01-13 |
2023-01-12 |
B
Purchase
|
BVF PARTNERS L P/IL
Non-Executive Director
|
15,912
+0.8%
31.24
497,132
USD
|
15,912
+0.8%
|
31.24
|
497,132
USD
|
|
2023-01-13 |
2023-01-12 |
B
Purchase
|
BVF PARTNERS L P/IL
Non-Executive Director
|
2,985
+0.1%
31.24
93,259
USD
|
2,985
+0.1%
|
31.24
|
93,259
USD
|
|
2023-01-13 |
2023-01-12 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
21,592
-2.4%
30.29
654,022
USD
|
21,592
-2.4%
|
30.29
|
654,022
USD
|
|
2023-01-13 |
2023-01-12 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
77,128
-1.5%
30.29
2,336,207
USD
|
77,128
-1.5%
|
30.29
|
2,336,207
USD
|
|
2023-01-13 |
2023-01-11 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
6,071
-0.7%
29.96
181,887
USD
|
6,071
-0.7%
|
29.96
|
181,887
USD
|
|
2023-01-13 |
2023-01-11 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
21,683
-0.4%
29.96
649,623
USD
|
21,683
-0.4%
|
29.96
|
649,623
USD
|
|
2023-01-13 |
2023-01-11 |
B
Purchase
|
BVF PARTNERS L P/IL
Non-Executive Director
|
11,149
+0.6%
29.89
333,209
USD
|
11,149
+0.6%
|
29.89
|
333,209
USD
|
|
2023-01-13 |
2023-01-11 |
B
Purchase
|
BVF PARTNERS L P/IL
Non-Executive Director
|
10,961
+0.4%
29.89
327,590
USD
|
10,961
+0.4%
|
29.89
|
327,590
USD
|
|
2023-01-13 |
2023-01-11 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
6,071
-0.7%
29.96
181,887
USD
|
6,071
-0.7%
|
29.96
|
181,887
USD
|
|
2023-01-13 |
2023-01-11 |
PS
Planned sale
|
Atlas Venture Fund X, L.P.
Large shareholder
|
21,683
-0.4%
29.96
649,623
USD
|
21,683
-0.4%
|
29.96
|
649,623
USD
|
|
2022-12-16 |
2022-12-15 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
717
-0.1%
30.00
21,510
USD
|
717
-0.1%
|
30.00
|
21,510
USD
|
|
2022-12-16 |
2022-12-15 |
PS
Planned sale
|
Booth Bruce
Non-Executive Director
|
2,561
-0.1%
30.00
76,830
USD
|
2,561
-0.1%
|
30.00
|
76,830
USD
|
|